Rocket Pharmaceuticals, Inc. (RCKT)
NASDAQ: RCKT · Real-Time Price · USD
3.190
+0.100 (3.24%)
Dec 3, 2025, 10:22 AM EST - Market open
Rocket Pharmaceuticals Market Cap
Rocket Pharmaceuticals has a market cap or net worth of $345.23 million as of December 3, 2025. Its market cap has decreased by -75.83% in one year.
Market Cap
345.23M
Enterprise Value
136.69M
1-Year Change
-75.83%
Ranking
Category
Stock Price
$3.19
Market Cap Chart
Since January 5, 2018, Rocket Pharmaceuticals's market cap has decreased from $413.75M to $345.23M, a decrease of -16.56%. That is a compound annual growth rate of -2.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 1, 2025 | 341.98M | -73.93% |
| Dec 31, 2024 | 1.31B | -51.45% |
| Dec 29, 2023 | 2.70B | 82.43% |
| Dec 30, 2022 | 1.48B | 5.29% |
| Dec 31, 2021 | 1.41B | -57.65% |
| Dec 31, 2020 | 3.32B | 169.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Jan 5, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 962.96B |
| Johnson & Johnson | 498.53B |
| AbbVie | 402.43B |
| UnitedHealth Group | 298.72B |
| AstraZeneca | 286.85B |
| Merck & Co. | 260.19B |
| Novartis AG | 249.40B |
| Abbott Laboratories | 224.14B |